Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database
A drier sublingual environment means the medication stays concentrated rather than immediately diluting with saliva
Bakirci, S., Dabague, J., Eder, L., McGonagle, D
It is important to emphasise that GLP-1 agonists are not a standalone solution but should form part of a comprehensive approach including dietary modification, physical activity, and behavioural support for optimal outcomes
Adjusting the Timing of Your GLP-1 Injections The timing of your GLP-1 injection can also influence how you experience nausea
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease